Electrochemotherapy and Other Clinical Applications of Electroporation for the Targeted Therapy of Metastatic Melanoma

• Main Authors: Corina Ioana Cucu, Călin Giurcăneanu, Liliana Gabriela Popa, Olguța Anca Orzan, Cristina Beiu, Alina Maria Holban, Alexandru Mihai Grumezescu, Bogdan Mircea Matei, Marius Nicolae Popescu, Constantin Căruntu, Mara Mădălina Mihai
• Format: Article
• Language: English
• Published: MDPI AG 2021-07-01
• Series: Materials
• Subjects: electrochemotherapy; electropermeabilization; electroporation; metastatic melanoma; advanced melanoma; targeted therapy
• Online Access: https://www.mdpi.com/1996-1944/14/14/3985

Electrochemotherapy (ECT) is an effective bioelectrochemical procedure that uses controlled electrical pulses to facilitate the increase of intracellular concentration of certain substances (electropermeabilization/ reversible electroporation). ECT using antitumor drugs such as bleomycin and cisplatin is a minimally invasive targeted therapy that can be used as an alternative for oncologic patients not eligible for surgery or other standard therapies. Even though ECT is mainly applied as palliative care for metastases, it may also be used for primary tumors that are unresectable due to size and location. Skin neoplasms are the main clinical indication of ECT, the procedure reporting good curative results and high efficiency across all tumor types, including melanoma. In daily practice, there are many cases in which the patient’s quality of life can be significantly improved by a safe procedure such as ECT. Its popularity must be increased because it has a safe profile and minor local adverse reactions. The method can be used by dermatologists, oncologists, and surgeons. The aim of this paper is to review recent literature concerning electrochemotherapy and other clinical applications of electroporation for the targeted therapy of metastatic melanoma.